Attovia Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ATTO | ACRS | ANNX | ARTV | DBVT | CANTA.ST | |
|---|---|---|---|---|---|---|
| Market cap | 712.16M | 570.34M | 820.88M | 206.32M | 624.64M | 475.36M |
| P/E (TTM) | — | — | — | — | — | 2.5 |
| Forward P/E | -6.6 | -5.1 | -4.0 | -2.1 | -25.6 | -1.8 |
| Price/book | -0.5 | 4.1 | 4.1 | 0.6 | 4.2 | 1.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −30.27% | +65.49% | +39.20% | +22.09% | −28.30% | −48.13% |
| Today | +2.16% | −1.60% | +3.34% | +0.48% | −1.68% | −2.09% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ATTO news ›ATLAUA Launches Botanical Recovery Shot
ATLAUA announced SOLACE, a botanical recovery blend served as a 2fl-oz (59mL) shot. SOLACE launched in November, direct at atlaua.shop and is now open for pre-order. ATLAUA was founded by former professional soccer player Adrian Goransch.…
Algorhythm Holdings interim CFO receives stock options
Algorhythm Holdings, Inc. (NASDAQ: RIME) is an AI logistics company built around SemiCab’s Collaborative Transportation Platform and Apex SaaS freight orchestration. - [Form 3] Algorhythm Holdings, Inc. Initial Statement of Beneficial…
Iambic Therapeutics director holds 66,556-share option
Mary Tagliaferri’s option expires August 26, 2034. Of the underlying shares, 25% vested August 13, 2025, with 1/48th vesting monthly thereafter. - [Form 3] Iambic Therapeutics, Inc. Initial Statement of Beneficial Ownership Iambic…
Attovia Therapeutics CFO ownership unchanged
The two options have exercise prices of $3.5302 and $4.9237 per share. Additional monthly vesting over three years is subject to continued service. - [Form 3/A] Attovia Therapeutics, Inc. Amended Initial Statement of Beneficial Ownership…
Attovia Therapeutics CEO Tao Fu holds 87,843 shares
Three direct stock-option positions cover 23,437, 409,709 and 370,290 shares, with vesting subject to continued service through each vesting date. - [Form 3/A] Attovia Therapeutics, Inc. Amended Initial Statement of Beneficial Ownership…
Attovia Therapeutics amends CEO option disclosure
Tao Fu’s options carry a $17 exercise price. Vesting starts with 25% on August 4, 2027, then monthly over 36 months, subject to continued service. - [Form 4/A] Attovia Therapeutics, Inc. Amended Insider Trading Activity Attovia…
Attovia Therapeutics CFO granted 140K stock options
Attovia Therapeutics (ATTO) amends CFO option-grant report with no ownership changes. Stock Titan - [Form 4/A] Attovia Therapeutics, Inc. Amended Insider Trading Activity Attovia Therapeutics CFO granted 140K stock options Twenty-five…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net6
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.